293 related articles for article (PubMed ID: 19293805)
1. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Torres-Rendon A; Roy S; Craig GT; Speight PM
Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
[TBL] [Abstract][Full Text] [Related]
2. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
Shetty A; Loddo M; Fanshawe T; Prevost AT; Sainsbury R; Williams GH; Stoeber K
Br J Cancer; 2005 Nov; 93(11):1295-300. PubMed ID: 16278669
[TBL] [Abstract][Full Text] [Related]
3. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
[TBL] [Abstract][Full Text] [Related]
4. DNA replication licensing factor MCM2, geminin, and Ki67 define proliferative state and are linked with survival in oral squamous cell carcinoma.
Al-Hazmi N; Alhazzazi T; Williams G; Stoeber K; Al-Dabbagh R
Eur J Oral Sci; 2018 Jun; 126(3):186-196. PubMed ID: 29745471
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
7. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
[TBL] [Abstract][Full Text] [Related]
8. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
[TBL] [Abstract][Full Text] [Related]
9. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.
Alaeddini M; Etemad-Moghadam S
Braz J Otorhinolaryngol; 2022; 88(4):529-532. PubMed ID: 32972865
[TBL] [Abstract][Full Text] [Related]
11. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions.
Razavi SM; Jafari M; Heidarpoor M; Khalesi S
Malays J Pathol; 2015 Dec; 37(3):253-8. PubMed ID: 26712671
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression of DNA replication factors in squamous cell carcinomas of the lip, face and oral cavity.
Etemad-Moghadam S; Mohammadpour H; Alaeddini M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e828-e832. PubMed ID: 35217222
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
[TBL] [Abstract][Full Text] [Related]
17. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma.
Kobayashi H; Sagara J; Masumoto J; Kurita H; Kurashina K; Taniguchi S
J Oral Pathol Med; 2003 Jul; 32(6):344-9. PubMed ID: 12787041
[TBL] [Abstract][Full Text] [Related]
18. Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients.
Wiphakphongpakorn P; Juengsomjit R; Poomsawat S; Meesakul O; Bhattarai BP; Klongnoi B; Buajeeb W; Khovidhunkit SP
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1257-1264. PubMed ID: 38679985
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
20. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
